Stay updated with breaking news from Inter Partes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a "listening session" focusing on USPTO-FDA collaboration initiatives proposed...
25.01.2023 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia) announces that the Patent Trial and Appeal Board (PTAB) of the United States’ Patent and Trademark Office has terminated the Inter Partes Review (IPR) it had instituted with respect to Aurinia’s ...
My practice focuses on patent disputes before district courts, the ITC and the PTAB. I began practicing in 2011 and have had the opportunity to work on cases involving a variety of technologies...
Under the Administrative Procedure Act, the Patent Trial and Appeal Board must fully and particularly set out the basis upon which it reached its decision. In Provisur Technologies Inc. v. Weber, the Federal Circuit found that the Board failed to meet this standard.
Patent Trademark Office PTO replace four legacy tools—Public-Examiner’s Automated Search Tool, Public-Web-Based Examiner’s Search Tool, Patent Full-Text and Image Database PatFT and Patent Application Full-Text and Image Database AppFT with new Patent Public Search Tool PPUBS.